from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0962c/lprP

LFCtreatmentdescriptionclass of inhibitor

0.293

Amikacinug/mL Amikacintranslation

0.336

Cap5-10ug/mL Capreomycintranslation

-0.068

Rox10-50 ug/mL Roxithromycintranslation

-1.534

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.333

Rif0.2-5ug/mL Rifampicintranscription

0.493

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.555

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.383

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

2.032

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.666

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.582

Nigericin50 uM Nigericinrespiration

0.100

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.818

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.565

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.356

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.170

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.379

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.317

Amp0.2mg/mL AmpicillincellWall

0.339

Cephalexin20-100 ug/mL CephalexincellWall

1.185

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.484

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.394

EMB10-20 ug/mL EthambutolcellWall

-0.583

Eta12-40 ug/mL EthionamidecellWall

-0.878

INH0.2-0.4 ug/mL IsoniazidcellWall

0.837

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.066

BZA0.12 mg/mL BenzamidearomaticAmides

0.122

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.108

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.400

H2O24 mM hydrogen peroxideDNAdamaging

-0.377

Levo10 ug/mL LevofloxacinDNAdamaging

-0.202

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.110

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.341

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.225

Antimycin12.5-50 ug/mL Antimycin A?

0.864

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.128

PA_110-50 ug/mL Antitubercular compound PA-1?

1.198

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.441

PA8240.2-2 ug/mL PA-824?

1.264

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.979

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.762

Verapamil50 uM Verapamil?

1.354

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?